CHAPTER-9 REFERENCES

7 BIBLIOGRAPHY AND REFERENCES

1. Russell RK and Satsangi J, “Does IBD run in families?” Inflamm Bowel Dis.2008, 14(2), 20-21.
2. Duricova D., Pedersen N., and Elkjaer M., “Overall and cause- specific mortality in
Crohn’s disease: a meta-analysis of population- based studies.” Inflamm Bowel Dis. 2010,
16, 347-53.
3. Kozuch PL and Hanauer SB, “Treatment of inflammatory bowel disease. A review of
medical therapy.” World J. Gastroenterol. 2008, 14(3), 354-377.
4. Atts P., Ileum L., “Colonic drug delivery.” Drug Dev Ind. Pharm. 1997, 23, 893-913.
5. Wood E, Wilson CG and Hardy JG, “The spreading of foam and solution enemas.”
[Link].1985, 25, 191-197.
6. Vyas SP., and Khar RK., In Gastroretentive systems: Controlled drug delivery- concepts
and advances; Vallabh Prakashan, New Delhi, 2005, pp 218-253.
7. Antonin KH., Rak R., Bieck PR., Preiss R., Schenker U., Hastewell J., Fox R. and Mackay
M., “The absorption of human calcitonin from the transverse colon of man.” J. Pharm.
Pharmacol. 1996, 130(1), 33-39.
8. Basit A., and Bloor J., “Perspectives on colonic drug delivery, Business briefing.”
Pharmtech. 2003, 185-190.
9. Watts P. and Illum L., “Colonic drug delivery.” Drug Dev Ind. Pharm. 1997, 23, 893-913.
10. Chien YW. In Novel drug delivery systems; Marcel Dekker Inc; 1992, pp 139-196.
11. Reddy MS., Sinha RV and Reddy DS, “Colon targeted systems.” Drugs Today. 1999, 35(7), 537.
12. Patel Asha, “Colon Targeted drug delivery system - A review. “Journal of Pharmaceutical
and Bio scientific research.” 2011, 1(1), 37-49.
13. Philip AK., Dubey RK and Pathak K., “Optimizing delivery of flurbiprofen to the colon
using a targeted prodrug approach.” J. Pharm. Pharmacol. 2008, 60, 607-613.
14. McLeod AD., Friend DR. and Thomas NT., “Glucocorticoid-dextran conjugates as
potential prodrugs for colon specific delivery - Hydrolysis in rat gastrointestinal tract
contents.” J. Pharm. Science. 1994, 83(9), 1284-1288.
15. Swarbrick J. and Boylan J.C., In Encyclopedia of Pharmaceutical Technology: Volume 2,
2nd Edn; American Chemical Society, New York. 2002, pp 939-2933.
16. Cole E., Scott R., Connor A., Wilding I., Petereit HU., Steinke C., Beckert T. and Cade D.,
“Enteric Coated HPMC Capsules Designed to Achieve Intestinal Targeting.” International
Journal of Pharmaceutics. 2002, 231, 83-95.

DEPT. OF PHARMACEUTICS DR SHRI RMS COP BHANPURA Page 91

17. Hardy J. G., Wilson C. G. and Wood E., “Drug delivery to the proximal colon.” J. Pharm. Pharmacol.
1985, 37, 874-877.

18. Ankush S., Kapil K., Amritpal S., Pooja and Anju, “A review on novel approaches for colon
targeted drug delivery system.” International journal of pharmaceutical chemical and
biological sciences.2014, 4(2), 241-249.
19. Rajguru V., Gaikwad P., Bankar V. and Pawar S., “An Overview on Colonic Drug Delivery System.”
International Journal of Pharmaceutical Sciences Review and Research. 2011, 6(2), 197-204.

20. Philip A. K. and Philip B., “Colon Targeted Drug Delivery Systems: A Review on
Primary and Novel Approaches.” Oman Medical Journal. 2010, 25(2), 70-78.
21. Padamala R., Kondeti R., Raju S. and Mulpuri K., “Colon drug delivery system: a novel
perspective.” World journal of pharmacy and pharmaceutical sciences. 2014, 3(9), 212-
227.
22. Kramer A., Turk S. and Vrecer F., “Statistical optimization of diclofenac sodium
sustained release pellets coated with polymethacrylic films.” J. Pharm. Pharmacol.2003,
256, 43-52.
23. Hardy J. G., Wilson C. G. and Wood E., “Drug delivery to the proximal colon.” J.
Pharm. Pharmacol.1985, 37, 874-877.
24. Davis S. S., “Assessment of gastrointestinal transit and drug absorption.” Novel Drug
Delivery and its Therapeutic Application. 1989, 89-101.
25. Rodriguez M., Vila J. L. and Torres D., “Design of a new multi particulate system for
potential site specific and controlled drug delivery to the colonic region.” J. Control
Rel.1998, 55, 67-77.
26. Sangeetha G., Begum M.J., Reddemma S. and Rajendra Y., “Colon Targeted Drug
Delivery System: A Review.” International Journal of Pharmacy and Technology. 2011,
3(4), 1657-1672.
27. Sreelatha D. and Brahma C. K., “Colon Targeted Drug Delivery – A Review on Primary
and Novel Approaches.” Journal of Global Trends in Pharmaceutical Sciences.2013, 4(3),
1174-1183.
28. Vinay K.V., Sivakumar T., Tamizhmani T., SundarRajan T. and Chandran I. S., “Colon
targeting drug delivery system: A review on recent approaches. ”J Pharm. Biomed Sci.
2011, 2(1), 11-19.
29. Koteshwara K.B. “Primary and novel approaches for colon targeted drug delivery– A review.”

DEPT. OF PHARMACEUTICS DR SHRI RMS COP BHANPURA Page 92

International Journal of Research in Ayurvedic& Pharmacy. 2011, 2(1), 60-65.

30. Bhushan Prabhakar Kolte, “Colon Targeted Drug Delivery System – A Novel
Perspective.” Asian journal of biomedical and pharmaceutical sciences. 2012, 2(14), 21-
28.
31. Aulton M.E., In Pharmaceutics: The Science of Dosage Form Design. International
Student Edition; 2001, pp 304-668.
32. Ansel H., Allen L., and Jr. Popovich N. In Ansel’s Pharmaceutical Dosage Forms and
Drug Delivery Systems; Eighth Edn; 2013, pp 227-259.
33. Willemijntje A., Hoogerwerf, Pasrichaand Pankaj Jay, In Pharmacotherapy, Goodman and
Gilman's the Pharmacological Basis of Therapeutics; 11th Edn; 2006, pp 623-634.
34. Bhaskaran S. and Lakshmi P.K., “Extrusion Spheronization- A Review.” J. Pharm. Tech res., 2010,
2(4), 2429-2433.

35. Rashmitha N. M., C. N. Somashekhar, and T. Tamizh Mani, “Pellets and pelletization - a
Review.” J. Pharm. Pharmacol. 2018, 2(4), 2429-2433.
36. Kawashima Y., Okumura M. and Takenaka H., “Spherical crystallization: direct spherical
agglomeration of Salicylic acid crystals during crystallization.” Science. 1982, 216(4),
1127-28.
37. Paradkar AR., Pawar AP., Mahadik KR. and Kadam SS., “Spherical crystallization: a
novel particle design technique.” Indian Drugs. 1994, 6, 229–233.
38. Jbilou M., Ettabia A., Guyot Hermann A. And Guyot JS., “Ibuprofen agglomeration
prepared by phase separation.” Ind. Pharm. Drug Dev. 1990, 25(3), 297-305.
39. Viswanathan CL, Kulkarni SK, and Kolwankar DR., “Spherical agglomeration of
mefenamic acid and nabumetone to improve micromeritic and solubility: A technical
note.” AAPS pharm sci. tech. 2006, 7(2), 48.
40. Jadhav N.R., “Pelletization by Extrusion Spheronization Technique: An Excipient
Review.” Drug Delivery Letters. 2012, 2, 1-14.
41. Zimm KR., Schwartz J.B. and Connor RE., “Drug release from multiparticulate pellet system.”
Pharma Dev Technology. 1996, 37-42.

42. Kandukuri J. M., Allenki V., EagaCM.,Keshetty V. and Jannu KK., “Pelletization
Techniques for Oral Drug Delivery.” J. Pharm. Sci. & Drug Res. 2009, 1(2), 63-70.
43. Steckel H., and Mindermann Nogly F., “Production of chitosan pellets by extrusion
Spheronization.” Eur. J. Pharm. Biopharm. 2004, 57, 107-13.
DEPT. OF PHARMACEUTICS DR SHRI RMS COP BHANPURA Page 93
 CHAPTER-9 REFERENCES

44. Kumar V., Mishra S.K., Lather A. and Singh R., “Multiple unit dosage form Pellet and
Pelletization Techniques: An over view.” Int. J. Res. Ayurveda and Pharm.2011, 2(1),
121-125.
45. Hogan, J. and Aulton, M., In Pharmaceutical coating technology, Coating Pans and
Coating Columns; Cole, G. Edn; London. 1995, pp 205–210.
46. Shama Parveen and M.P. Khinchi, “Recent Advancement in Tablet Coating
Technology.” World Journal of Pharmacy and Pharmaceutical Sciences. 2017, 6(4),
2189-2204.

DEPT. OF PHARMACEUTICS DR SHRI RMS COP BHANPURA Page 94

DEPT. OF PHARMACEUTICS DR SHRI RMS COP BHANPURA Page 95